298 related articles for article (PubMed ID: 31561043)
1. Design and development of molecular hybrids of 2-pyridylpiperazine and 5-phenyl-1,3,4-oxadiazoles as potential multifunctional agents to treat Alzheimer's disease.
Tripathi A; Choubey PK; Sharma P; Seth A; Tripathi PN; Tripathi MK; Prajapati SK; Krishnamurthy S; Shrivastava SK
Eur J Med Chem; 2019 Dec; 183():111707. PubMed ID: 31561043
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and biological evaluation of ferulic acid based 1,3,4-oxadiazole hybrids as multifunctional therapeutics for the treatment of Alzheimer's disease.
Tripathi A; Choubey PK; Sharma P; Seth A; Saraf P; Shrivastava SK
Bioorg Chem; 2020 Jan; 95():103506. PubMed ID: 31887472
[TBL] [Abstract][Full Text] [Related]
3. Novel Molecular Hybrids of
Sharma P; Tripathi A; Tripathi PN; Singh SS; Singh SP; Shrivastava SK
ACS Chem Neurosci; 2019 Oct; 10(10):4361-4384. PubMed ID: 31491074
[TBL] [Abstract][Full Text] [Related]
4. Design and development of multitarget-directed N-Benzylpiperidine analogs as potential candidates for the treatment of Alzheimer's disease.
Sharma P; Tripathi A; Tripathi PN; Prajapati SK; Seth A; Tripathi MK; Srivastava P; Tiwari V; Krishnamurthy S; Shrivastava SK
Eur J Med Chem; 2019 Apr; 167():510-524. PubMed ID: 30784883
[TBL] [Abstract][Full Text] [Related]
5. Lead optimization based design, synthesis, and pharmacological evaluation of quinazoline derivatives as multi-targeting agents for Alzheimer's disease treatment.
Verma A; Waiker DK; Singh N; Singh A; Saraf P; Bhardwaj B; Kumar P; Krishnamurthy S; Srikrishna S; Shrivastava SK
Eur J Med Chem; 2024 May; 271():116450. PubMed ID: 38701714
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and biological evaluation of some 2-(3-oxo-5,6-diphenyl-1,2,4-triazin-2(3H)-yl)-N-phenylacetamide hybrids as MTDLs for Alzheimer's disease therapy.
Waiker DK; Verma A; Gajendra TA; Namrata ; Roy A; Kumar P; Trigun SK; Srikrishna S; Krishnamurthy S; Davisson VJ; Shrivastava SK
Eur J Med Chem; 2024 May; 271():116409. PubMed ID: 38663285
[TBL] [Abstract][Full Text] [Related]
7. Design and development of novel N-(pyrimidin-2-yl)-1,3,4-oxadiazole hybrids to treat cognitive dysfunctions.
Tripathi PN; Srivastava P; Sharma P; Seth A; Shrivastava SK
Bioorg Med Chem; 2019 Apr; 27(7):1327-1340. PubMed ID: 30795991
[TBL] [Abstract][Full Text] [Related]
8. Design, Synthesis, and Biological Investigation of Quinazoline Derivatives as Multitargeting Therapeutics in Alzheimer's Disease Therapy.
Verma A; Waiker DK; Singh N; Roy A; Singh N; Saraf P; Bhardwaj B; Krishnamurthy S; Trigun SK; Shrivastava SK
ACS Chem Neurosci; 2024 Feb; 15(4):745-771. PubMed ID: 38327209
[TBL] [Abstract][Full Text] [Related]
9. Design and development of 1,3,4-oxadiazole derivatives as potential inhibitors of acetylcholinesterase to ameliorate scopolamine-induced cognitive dysfunctions.
Mishra P; Sharma P; Tripathi PN; Gupta SK; Srivastava P; Seth A; Tripathi A; Krishnamurthy S; Shrivastava SK
Bioorg Chem; 2019 Aug; 89():103025. PubMed ID: 31176239
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and evaluation of novel tacrine-(β-carboline) hybrids as multifunctional agents for the treatment of Alzheimer's disease.
Lan JS; Xie SS; Li SY; Pan LF; Wang XB; Kong LY
Bioorg Med Chem; 2014 Nov; 22(21):6089-104. PubMed ID: 25282654
[TBL] [Abstract][Full Text] [Related]
11. Development of chalcone-O-alkylamine derivatives as multifunctional agents against Alzheimer's disease.
Bai P; Wang K; Zhang P; Shi J; Cheng X; Zhang Q; Zheng C; Cheng Y; Yang J; Lu X; Sang Z
Eur J Med Chem; 2019 Dec; 183():111737. PubMed ID: 31581002
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and biological activity of novel donepezil derivatives bearing N-benzyl pyridinium moiety as potent and dual binding site acetylcholinesterase inhibitors.
Lan JS; Zhang T; Liu Y; Yang J; Xie SS; Liu J; Miao ZY; Ding Y
Eur J Med Chem; 2017 Jun; 133():184-196. PubMed ID: 28388521
[TBL] [Abstract][Full Text] [Related]
13. Discovery of novel series of 2-substituted benzo[d]oxazol-5-amine derivatives as multi-target directed ligands for the treatment of Alzheimer's disease.
Gutti G; Kakarla R; Kumar D; Beohar M; Ganeshpurkar A; Kumar A; Krishnamurthy S; Singh SK
Eur J Med Chem; 2019 Nov; 182():111613. PubMed ID: 31437780
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and biological evaluation of new coumarin-dithiocarbamate hybrids as multifunctional agents for the treatment of Alzheimer's disease.
Jiang N; Huang Q; Liu J; Liang N; Li Q; Li Q; Xie SS
Eur J Med Chem; 2018 Feb; 146():287-298. PubMed ID: 29407958
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective effects of bergenin in Alzheimer's disease: Investigation through molecular docking, in vitro and in vivo studies.
Barai P; Raval N; Acharya S; Borisa A; Bhatt H; Acharya N
Behav Brain Res; 2019 Jan; 356():18-40. PubMed ID: 30118774
[TBL] [Abstract][Full Text] [Related]
16. Donepezil-butylated hydroxytoluene (BHT) hybrids as Anti-Alzheimer's disease agents with cholinergic, antioxidant, and neuroprotective properties.
Cai P; Fang SQ; Yang HL; Yang XL; Liu QH; Kong LY; Wang XB
Eur J Med Chem; 2018 Sep; 157():161-176. PubMed ID: 30096650
[TBL] [Abstract][Full Text] [Related]
17. Novel tacrine-tryptophan hybrids: Multi-target directed ligands as potential treatment for Alzheimer's disease.
Chalupova K; Korabecny J; Bartolini M; Monti B; Lamba D; Caliandro R; Pesaresi A; Brazzolotto X; Gastellier AJ; Nachon F; Pejchal J; Jarosova M; Hepnarova V; Jun D; Hrabinova M; Dolezal R; Zdarova Karasova J; Mzik M; Kristofikova Z; Misik J; Muckova L; Jost P; Soukup O; Benkova M; Setnicka V; Habartova L; Chvojkova M; Kleteckova L; Vales K; Mezeiova E; Uliassi E; Valis M; Nepovimova E; Bolognesi ML; Kuca K
Eur J Med Chem; 2019 Apr; 168():491-514. PubMed ID: 30851693
[TBL] [Abstract][Full Text] [Related]
18. Development of cyanopyridine-triazine hybrids as lead multitarget anti-Alzheimer agents.
Maqbool M; Manral A; Jameel E; Kumar J; Saini V; Shandilya A; Tiwari M; Hoda N; Jayaram B
Bioorg Med Chem; 2016 Jun; 24(12):2777-88. PubMed ID: 27157006
[TBL] [Abstract][Full Text] [Related]
19. Multifunctional scutellarin-rivastigmine hybrids with cholinergic, antioxidant, biometal chelating and neuroprotective properties for the treatment of Alzheimer's disease.
Sang Z; Li Y; Qiang X; Xiao G; Liu Q; Tan Z; Deng Y
Bioorg Med Chem; 2015 Feb; 23(4):668-80. PubMed ID: 25614117
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation of multi-target-directed ligands for the treatment of Alzheimer's disease based on the fusion of donepezil and melatonin.
Wang J; Wang ZM; Li XM; Li F; Wu JJ; Kong LY; Wang XB
Bioorg Med Chem; 2016 Sep; 24(18):4324-4338. PubMed ID: 27460699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]